The Invesco S&P MidCap 400 Pure Growth ETF (Fund) is based on the S&P MidCap 400 Pure Growth Index (Index). The Fund will invest at least 90% of its total assets in securities that comprise the Index. The Index measures the performance of securities that exhibit strong growth characteristics in the S&P MidCap 400 Index. Growth is measured by the following risk factors: sales growth, earnings change to price and momentum. The Fund and the Index are rebalanced annually.
Invesco S&P MidCap 400 Pure Growth ETF · Issued by Invesco
| HALO | Halozyme Therapeutics Inc | 2.66% |
| ARWR | Arrowhead Pharmaceuticals Inc | 2.42% |
| FTI | TechnipFMC PLC | 2.35% |
| CRS | Carpenter Technology Corp | 2.04% |
| IDCC | InterDigital Inc | 1.89% |
| TWLO | Twilio Inc Class A | 1.86% |
| ATI | ATI Inc | 1.85% |
| FIVE | Five Below Inc | 1.84% |
| MEDP | Medpace Holdings Inc | 1.83% |
| VAL | Valaris Ltd | 1.83% |
No recent news for RFG. The ingest cron pulls every 15 minutes during market hours.